Nasdaq:US$17.90 (+0.96) | HKEX:HK$28.35 (+1.45) | AIM:£2.89 (+0.13)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate